期刊文献+

肥厚型心肌病的诊断和防治进展 被引量:7

Advances in the diagnosis and treatment of hypertrophic cardiomyopathy
下载PDF
导出
摘要 肥厚型心肌病(HCM)是由编码心肌肌节蛋白的基因突变所导致的最常见的遗传性心脏病,是青年人及运动员心原性猝死的主要原因。临床表现复杂多样,可表现为无症状、心绞痛、晕厥和猝死等。影像学诊断是目前HCM的主要诊断方法。治疗以缓解症状和防治并发症为主,包括药物治疗和非药物治疗。近年来,基因检测也逐渐应用于该病的早期诊断、危险分层、个体化治疗及优生优育。本文主要对HCM的诊断、治疗和早期预防等方面的研究进展进行综述。 Hypertrophic cardiomyopathy( HCM) is the most common hereditary heart disease caused by mutations in genes encoding sarcomere protein,and is the leading cause of sudden cardiac death among young people and athletes. The clinical manifestations of HCM are complicated and diverse,can be present as asymptomatic,angina pectoris,syncope or sudden death. Imaging diagnosis is the main diagnostic method of HCM. Main treatment include symptoms alleviation and prevention complications,which can be classified as medication and non-medication treatment. In recent years,genetic testing has been gradually used for the early diagnosis,risk stratification,individualized treatment and prenatal care. The advances of diagnosis,treatment and early prevention of HCM will be reviewed in this article.
作者 赵梦林 于婕 祖凌云 Zhao Menglin Yu Jie Zu Lingyun(Department of Cardiology and Institute of Vascular Medicine ,Peking University Third Hospital,Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, National Health and Family Planning Commission, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education,Beijing Key Laboratory of Cardiovascular Receptors Research. Beijing 100191, China)
出处 《中国心血管杂志》 2017年第5期364-368,共5页 Chinese Journal of Cardiovascular Medicine
基金 国家自然科学基金项目(81670323)~~
关键词 肥厚型心肌病 诊断 治疗 基因检测 Hypertrophic cardiomyopathy Diagnosis Treatment Genetic testing
  • 相关文献

参考文献7

二级参考文献34

  • 1Konno T,ChangS,Seidman JG. Genetics of hypertrophic cardiomyopathy[J].Current Opinion in Cardiology,2010,(03):205-209.
  • 2Hagège AA,Desnos M. New trends in treatment of hypertro-phic cardiomyopathy[J].Archives of Cardiovascular Diseases,2009,(05):441-447.
  • 3Maron BJ,Estes NA 3rd,Maron MS. Primary preventinon of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy[J].Circulation,2003,(23):2872-2875.
  • 4Mazur W,Nagueh SF,Lakkis NM. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy[J].Circulation,2001,(11):1492-1496.
  • 5Fosslien E. Mitochondrial medicine--cardiomyopathy caused by defective oxidative phosphorylation[J].Annals of Clinical and Laboratory Science,2003,(04):371-395.
  • 6R Alcalai,JG Seidman,CE Seidman.Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics[].Journal of Cardiovascular Electrophysiology.2008
  • 7Camillo A,Maria RC,Marco P,et al.Risk Associated With Pregnancy in Hypertrophic Cardiomyopathy[].Journal of the American College of Cardiology.2002
  • 8Richard P,Charron P,Carrier L,et al.Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy[].Circulation.2003
  • 9Marian AJ.Hypertrophic cardiomyopathy:from genetics to treatment[].European Journal of Clinical Investigation.2010
  • 10Mogensen J,Murphy RT,Kubo T,et al.Frequency and clinical ex-pression of cardiac troponin I mutations in748consecutive families with hypertrophic cardiomyopathy[].Journal of the American College of Cardiology.2004

共引文献12

同被引文献26

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部